资源描述:
《人造血干细胞扩增的研究进展论文》由会员上传分享,免费在线阅读,更多相关内容在工程资料-天天文库。
1、人造血干细胞扩增的研究进展论文关键词:干细胞人造血progressonStudyofTechniquesforExpansionofHumanHematopoieticStemCells造血干细胞(llematopoieticstemcells,HSC)移植可能使遗传血液病、免疫缺陷病及恶性肿瘤等完全治愈,由于HSC移植存在以下不足而受限制:⑴为获得足够量移植用HSC,必须进行大规模的骨髓抽吸或餐周血分离;⑵获得的HSC量有限;⑶HSC输注后产生的成熟细胞的生物动力欠佳,移植后1-3周内并无直接治疗疗效。移植前
2、HSC培养扩增,可解决这些难题。当前主要有两种:⑴细胞因子支持下筛选CD34+细胞的体外扩增;⑵基质支持下的灌注培养。下面就HSC培养的发展、HSC扩增方法以及展望等作一综述。1早期HSC培养及启示1半固体培养体系1966年,Bradley等1介绍了一种新的半固体培养方法(即集落形成法)用以培养骨髓。此法利用胶体凝胶作支托,没有细胞微环境,只能维持造血祖细胞在1-2周内形成细胞集落.freell-1的浆灌注为0.1ml·kg-1·min-1,相当于细胞密度为106·ml-1,含20%血清的培养介质,每天全部更换
3、一次。SchousemarroopoieticstemcellsinvitroJCellsPysiol,1977;91:335GartnerS,etal.Longtermcultureofhumanbonemarroechanismsitivehumanhematopoiesis,Blood,1993;81:1465LansdorpPM,etal.Ontogeny-relatedchange:inproliferativepotentialofhumanhematopoieticcells.JExpMed,19
4、93;178:787MetcalfD,.freelatopoieticregulator:redundancyorsubtlety?Blood,1993:82:3515HeimfiedS,etal.ExvivoexpansionanalysisfromCD34+HLA-BRI,CD34±andCD38+subestEepHematol,1994(Abstr):22:756BjomsonBH.etal.InhitionofCFU-NMandCFU-Eosbymatruregranulocytes,Blood,19
5、84:63:376TavassoliM,Hematopoeticsurvivalfactro.ExpHematol,1993;21:1411MooreMA,Expansionofmyeloidstemcellsinculture.SeminHematol,199:32:183HaylockND,etal.ExvivoecpansionandmaturationofperipheralbloodCD34+cellsintothemyeloidlineage,Blood,1992;80:4405SatoNetal.
6、vitroexpansionofhumanperipheralbloodCD34+cells,Blood,1993;82:3600BruggerayaniH,etal.Cytokine-inducedselectiverexpansionandmaturationoferythroidversusmyeloidcordbloodprecurrsorcell.Blood,1993;81:3252NakahataT,Expansionofhematopoieticprogenitors.In:BajusJL,eta
7、l.eds,EducationProgramofThe26thCongressofTheIntemationalSocietyofHaematologySingapore,1996;29-302OsykaTetal.Theeffectsofinterleukin-6andinterleukin-3onearlyhematopoieticeventsinlong-termculturesofhumanmarroatol,1991;19:1042KollerMR,etal.Long-termcultureiniti
8、atingcellexpansionisdependentonfrequentmediumexchangebinedalandotheraccessorycelleffects.Blood,1995;86:1784KollerMR,etal.Expansionofprimitaivehumanhematopoieticprogenitorsinaperfusionbioreactors